Doç. Dr.Sait Burak Erer

  • İlgi Alanları
  • Romatoid artrit
  • Ankilozan spondilit
  • Ailevi akdeniz ateşi
  • Behçet hastalığı

Eğitim ve Uzmanlık
1997 – 9 Eylül Üniversitesi Tıp Fakültesi – Tıp eğitimi
2002 – İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç Hastalıkları – Uzmanlık
2007 – İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Romatoloji – Uzmanlık

Deneyim
2007-2009 – İstanbul Ümraniye Eğitim ve Araştırma Hastanesi Romatoloji polikliniğinde mecburi hizmet
2009-2012 – İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç Hastalıkları Anabilim Dalı Romatoloji BD’da Uzman
2012-2016 – İstanbul Üniversitesi, İstanbul Tıp Fakültesi, İç Hastalıkları Anabilim Dalı Romatoloji BD’da Doçent
2017-2020 Medistate Kavacık Hastanesi Romatoloji Kliniği

Mesleki Üyelikler
İç Hastalıkları Derneği Üyesi
Romatoloji Derneği Üyesi
İstanbul Tabip Odası Üyesi

Ödüller
Türkiye Romatoloji Derneği Deneysel Araştırma İkincilik Ödülü (2014)
"Behçet Hastalığında KIR3DL1/KIR3DS1 Reseptörlerinin Rolünün Değerlendirilmesi"
Sait Burak Erer, Elaine F Remmers, Masaki Takeuchi, Colleen Satorius, Duran Üstek, İlknur Tuğal Tutkun, Emire Seyahi, Yılmaz Özyazgan, Daniel L Kastner, Michael J Ombrello, Ahmet Gül.
Türkiye Romatoloji Derneği Bildiri Ödülleri Üçüncülük Ödülü (2013)
“Sistemik Skleroz Hastalarında Tırnak-Dibi Video-Kapillaroskopi Bulguları ile Çözünür Biyobelirteçler Arasındaki İlişkinin Araştırılması: Erken-Aktif Bulguları Olan Hastalarda Cd40l’nın Önemi”
Yasemin Yalçınkaya, Suzan Adın Çınar, Sevil Kamalı, Özlem Pehlivan, Nilüfer Alpay Kanıtez, Burak Erer, Lale Öcal, Günnur Deniz, Murat İnanç
Türkiye Romatoloji Derneği Özel Ödülü (2012)
“Uzun süredir takibi sürdürülen Takayasu arteriti kohortunda hasarın vaskülit hasar indeksi ile kesitsel değerlendirilmesi”
Ahmet Omma, Burak Erer, Yasemin Şahinkaya, Özlem Pehlivan, Nilüfer Alpay Kanıtez, Lale Öcal, Murat Inanç, Sevil Kamalı.

Araştırma ve Yayınlar(varsa-Sayısı Mühim Değil):

Uluslararası hakemli dergilerde yayımlanan makaleler:

1.            Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016. J Rheumatol. 2017 Nov;44(11):1750-1753.

 

2.            Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, Le J, Blake M, Erer B, Kawagoe T, Ustek D, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sousa I, Davatchi F, Francisco V, Shahram F, Abdollahi BS, Nadji A, Shafiee NM, Ghaderibarmi F, Ohno S, Ueda A, Ishigatsubo Y, Gadina M, Oliveira SA, Gül A, Kastner DL, Remmers EF. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility. Nat Genet. 2017 Mar;49(3):438-443.

 

3.            Erer B, Masaki Takeuchi, Duran Ustek, Ilknur Tugal-Tutkun, Emire Seyahi, Yilmaz Ozyazgan, Julide Duymaz-Tozkir, Ahmet Gul, Daniel Kastner, Elaine Remmers, and Michael Ombrello. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease. Genes Immun. 2016 Dec;17(7):396-399. doi: 10.1038/gene.2016.36.

 

4.            A. Omma, B. Erer, O. Karadag, N. Yilmaz, F. Alibaz Oner, F. Yildiz, M. Kalfa, G. Kimyon, S. Kiraz, H. Direskeneli, E. Erken, K. Aksu, A. Onat, A. Gül, L. Ocal, M. Inanc, S. Kamali. Remarkable damage along with poor quality of life in Takayasu arteritis: Cross-sectional results of a long-term followed-up multi-center cohort.  Clin Exp Rheumatol. 2016 Nov 10. [Epub ahead of print]

 

5.            Toz B, Erer B. Biologic therapy in familial Mediterranean fever: Comment on the study by Koga et al. Mod Rheumatol. 2016 Jun 16:1. [Epub ahead of print]

 

6.            Toz B, Erer B. Comment on "Polyarteritis nodosa: A contemporary overview". Autoimmun Rev. 2016 May 25. pii: S1568-9972(16)30107-0. doi:10.1016/j.autrev.2016.05.002. [Epub ahead of print]

 

7.            Toz B, Erer B. Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al. Clin Rheumatol. 2016 May 3. [Epub ahead of print]

 

8.            Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Watts NR, Gül A, Kastner DL, Remmers EF. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers. Ann Rheum Dis. 2016 May 23. pii: annrheumdis-2015-209059. doi: 10.1136/annrheumdis-2015-209059. [Epub ahead of print]

 

9.            Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016 Jan 22. pii: annrheumdis-2015-208690. doi: 10.1136/annrheumdis-2015-208690. [Epub ahead of print] PubMed PMID: 26802180.

 

10.         Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int. 2015 Dec 28. [Epub ahead of print] PubMed PMID: 26712372.

 

11.         Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever. Arthritis Res Ther. 2015 Sep 4;17:243.

 

12.         Demirkaya E, Erer B, Ozen S, Ben-Chetrit E. Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review. Rheumatol Int. 2015 Dec 19. [Epub ahead of print] PubMed PMID: 26687683.

 

13.         Kanıtez NA, Toz B, Güllüoğlu M, Erer B, Esen BA, Omma A, Şahinkaya Y, İliaz R, Çavuş B, Gül A, İnanç M, Karaca Ç, Kamalı S. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities. Clin Rheumatol. 2016 Jan 7. [Epub ahead of print] PubMed PMID:26742755.

 

14.         Demir S, Artim-Esen B, Şahinkaya Y, Pehlivan Ö, Alpay-Kanıtez N, Omma A, Erer B, Kamalı S, Gül A, Aral O, Öcal L, İnanç M. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients. Lupus. 2016 Feb;25(2):177-84.

 

15.         Saribayev M, Tufan F, Oz F, Erer B, Ozpolat T, Ozturk GB, Akin S, Saka B, Erten N, Tascioglu C, Karan A. Corticosteroid treatment normalizes QTc prolongation and improves heart block in an elderly patient with anti-Ro-positive systemic lupus erythematosus. Aging Clin Exp Res. 2014 Jun;26(3):337-9.

 

16.         Alpay-Kanitez N, Omma A, Erer B, Artim-Esen B, Gül A, Inanç M, Öcal L, Kamali S. Favourable pregnancy outcome in Takayasu arteritis: a single-centre experience. Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-7-10.

 

17.         Demir A, Akyüz F, Göktürk S, Evirgen S, Akyüz U, Örmeci A, Soyer Ö, Karaca C, Demir K, Gundogdu G, Güllüoğlu M, Erer B, Kamalı S, Kaymakoglu S, Besisik F, Gül A. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scand J Gastroenterol. 2014 Dec;49(12):1414-8.

 

18.         Alpay N, Hançer VS, Erer B, İnanç M, Diz-Küçükkaya R. The Relationship between P-Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome: A Pilot Case-Control Study. Turk J Haematol. 2014 Dec 5;31(4):357-62.

 

19.         Yalcinkaya Y, Pehlivan O, Omma A, Alpay N, Erer B, Kamali S, Ocal L, Inanc M. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S92-7.

 

20.         Alpay Kanıtez N, Erer B, Doğan Ö, Büyükbabani N, Baykal C, Sindel D, Tanakol R, Yavuz AS. Osteoporosis and osteopathy markers in patients with mastocytosis. Turk J Haematol. 2015 Mar 5;32(1):43-50.

 

21.         Yildirim Cetin G, Ganiyusufoglu E, Solmaz D, Cagatay Y, Yılmaz Oner S, Erer B, Sagliker HS, Avci AB, Akar S, Pamuk ON, Kılınc M, Kasifoglu T, Direskeneli H, Gul A, Sayarlioglu M. The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis. Amyloid. 2015;22(3):207-8.

 

22.         Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Ugurlu S, Erer B, Abaci N, Ustek D, Meguro A, Ueda A, Takeno M, Inoko H, Ombrello MJ, Satorius CL, Maskeri B, Mullikin JC, Sun HW, Gutierrez-Cruz G, Kim Y, Wilson AF, Kastner DL, Gül A, Remmers EF. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in  Behcet disease. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8134-9. doi: 10.1073/pnas.1306352110.

 

23.         Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH.Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2013 Mar 2. [Epub ahead of print] PubMed PMID: 23455632.

 

24.         Erer B, Cosan F, Oku B, Ustek D, Inanc M, Aral O, Gul A. MEFV gene variations  in patients with systemic lupus erythematosus. Mod Rheumatol. 2014 Jan;24(1):93-6.

 

25.         Parlakgul G, Guney E, Erer B, Kılıcaslan Z, Direskeneli H, Gul A, Saruhan-Direskeneli G. Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease. Arthritis Res Ther. 2013 Jan 21;15(1):R15.

 

26.         Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, Kastner DL. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013 Feb;45(2):202-7. doi: 10.1038/ng.2520. Epub 2013 Jan 6. PubMed PMID: 23291587.

 

27.         Hasiloglu ZI, Asik M, Erer B, Dikici AS, Altintas A, Albayram S. Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review.  Rheumatol Int. 2012 Nov;32(11):3679-81. doi: 10.1007/s00296-011-2105-6.

 

28.         Kamali S, Artim-Esen B, Erer B, Ozdener L, Gul A, Ocal L, Aral O, Inanc M. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. Clin Rheumatol. 2012 Feb;31(2):325-8. doi: 10.1007/s10067-011-1793-3

 

29.         Hasiloglu ZI, Albayram S, Tasmali K, Erer B, Selcuk H, Islak C. A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement. Rheumatol Int. 2012 Mar;32(3):805-7. doi: 10.1007/s00296-011-1824-z.

 

30.         Ünlü E, Pamuk ÖN, Erer B, Dönmez S, Çakir N. Diaphragmatic movements in ankylosing spondylitis patients and their association with clinical factors: an ultrasonographic study. Rheumatol Int. 2012 Feb;32(2):435-7. doi: 10.1007/s00296-010-1657-1.

 

31.         Bulakci M, Yahyayev A, Ucar A, Erer B, Erer B, Dursun M. Unusual cause of right ventricular outflow tract compression: mediastinal lipomatosis. J Thorac Imaging. 2011 Nov;26(4):W134-6. doi: 10.1097/RTI.0b013e3181f46191.

 

32.         Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O'Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet. 2010 Aug;42(8):698-702. Epub 2010 Jul 11. PubMed PMID: 20622878; PubMed Central PMCID: PMC2923807.

 

33.         Atagunduz P, Aydin SZ, Bahadir C, Erer B, Direskeneli H. Determinants of early radiographic progression in ankylosing spondylitis. J Rheumatol. 2010 Nov;37(11):2356-61. Epub 2010 Sep 15. PubMed PMID: 20843901.

 

34.         Erer B, Erer B, Nurkalem Z, Lutfu Orhan A, Ozdil K, Eren M. A fatal case of Behcet's disease. Int Angiol. 2011 Feb;30(1):92-4. PubMed PMID: 21248679.

 

 

35.         Kamali S, Artim-Esen B, Erer B, Ozdener L, Gul A, Ocal L, Aral O, Inanc M. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. Clin Rheumatol. 2011 Aug 4. [Epub ahead of print] PubMed PMID: 21814755.

 

36.         Yazici S, Yazici M, Erer B, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet  indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010;21(2):122-5.

 

37.          Yazici S, Yazici M, Erer B, Erer B, Calik Y, Bulur S, Ozhan H, Ataoglu S. The  platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets. 2010;21(2):126-31.

 

38.         Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients. J Rheumatol. 2010 Feb;37(2):374-8.

 

39.         Aydin SZ, Atagunduz P, Erer B, Bahadir C, Inanc N, Direskeneli H. Mannose binding lectin levels are not related to radiographic damage in ankylosing spondylitis. Rheumatol Int. 2010 Jan;30(3):415-7.

 

40.         Erer B, Kamali S, Cingu K, Kilicaslan I, Gul A, Inanc M, Aral O, Tugal-Tutkun  I. Recurrent anterior uveitis in Henoch Schonlein's vasculitis. Rheumatol Int. 2009 Jul 29.

 

41.         Erer B, Yilmaz G, Yilmaz FM, Koklu S. Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy. Rheumatol Int. 2009 Apr;29(6):651-4.

 

42.         Tahan V, Sayrak H, Bayar N, Erer B, Tahan G, Dane F. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J. 2008 Sep 8;1(1):144.

 

43.         Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, Sut N, Hacibekiroglu M, Imeryuz N, Senturk H. Leptin in nonalcoholic fatty liver disease. Ann Hepatol. 2008 Jul-Sep;7(3):249        54.

 

44.         Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Autoimmune hepatitis induce by the prolonged hepatitis A virus infection. Ann Hepatol. 2008 Apr-Jun;7(2):177-9.

 

45.         Pay S, Oztürk MA, Can G, Cefle A, Cobankara V, Erer B, Göğüş F, Hatemi G, Inanç N, Karaaslan Y, Karadağ O, Karakoç Y, Günal EK, Kaşifoğlu T, Keser G, Koca S, Oktem S, Ozer HT, Sayarlioğlu M, Soy M, Sentürk T, Temel M, Terzioğlu E, Tiryaki O, Türk T, Yücel E. Society for Research and Education in Rheumatology of Turkey. Risk of cancer in Turkish patients after treatment with TNF antagonists. Rheumatology (Oxford).2008 Apr;47(4):548-9.

 

46.         Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O. Safety of high-dose   intravenous immunoglobulin in systemic autoimmune diseases. Clin Rheumatol. 2007 Nov;26(11):1913-5. Epub 2007 Jul 18.

 

 

47.         Dursun M, Yilmaz S, Erer B, Eralp L. Clinical image: pigmented villonodular synovitis of the knee. Arthritis Rheum. 2006 Nov;54(11):3422.

 

48.         Oflaz H, Mercanoglu F, Karaman O, Kamali S, Erer B, Genchellac H, Pamukcu B, Umman S, Inanc M, Gul A. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract. 2005 Jul;59(7):777-81.

 

49.         Kalayoğlu-Beşişik S, Abdul-Rahman IS, Erer B, Yenerel MN, Oğuz FS, Tunç M, Sargin D.Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis. J Urol. 2003 Sep;170(3):922.

 

50.         Onat A, Ceyhan K, Erer B, Başar O, Uysal O, Sansoy V. Systolic, diastolic, and pulse pressures as coronary risk factors in a population with low cholesterol  levels: a prospective 10-year evaluation. Clin Cardiol. 2003 Feb;26(2):91-7.

 

51.         Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis. 2002 Dec;165(2):285-92.

 

52.         Onat A, Ceyhan K, Sansoy V, Basar O, Erer B, Uysal O, Hergenç G. Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women. Int J Cardiol. 2002 Nov;86(1):61-9. 

 

53.         Erer B, Erer B, Oflaz H, Gorgulu S, Kamali S, Karaman O, Inanc M. Assessment of Subclinical Cardiac Dysfunction in Diffuse Scleroderma Patients. Balkan Med J. 2010;27(3):243-47.

 

54.         Erer B, Yazici S, Yilmaz G, Yilmaz FM, Erer B, Yuksel H. Assessment of Serum Sialic Acid and Oxidative Stres Parameters in Rheumatoid Arthritis Patients Receiving Anti-TNF-α and Conventional Therapies. Turk J Phys Med Rehab 2010;56:182-5.